More good news in the horizon for people with acromegaly

September 29, 2026

MAR002 is an early, promising development: a new take on a proven strategy, with the potential for stronger IGF-1 control and dramatically less frequent dosing. At the same time, it’s important to keep expectations grounded. The drug is still investigational. It is not approved, not yet available outside clinical trials, and a larger patient study is needed to confirm what the early data suggest.

Nonfunctional Pituitary Adenomas

September 23, 2014

From Lewis Blevins, MD – We really shouldn’t call them nonfunctional pituitary adenomas. They are living tissue and thus “functioning.” The term comes from the fact that they are not producing any hormones in excess

Testosterone

September 22, 2014

From Lewis Blevins, MD – Photo from The Huffington Post – Testosterone use in men has been “associated” with cardiovascular risk. In my opinion, this is because men with cardiovascular disease, who are obviously sick,

Oxytocin

September 22, 2014

From Lewis Blevins. MD I’ve been asked on at least two occasions to comment on oxytocin in patients with hypothalamic and pituitary disorders. Oxytocin is a fascinating hormone made by the hypothalamus. It is stored

The Hypothalamus

September 15, 2014

From Lewis Blevins, MD – Image from UPMC –  The hypothalamus is recognized as the part of the brain that surrounds the third ventricle. It contains the cell bodies of neurons that release hypothalamic hormones

Welcome to Pituitary World News

September 4, 2014

Welcome to Pituitary World News. Our goal is to educate, inform and provide a platform to exchange ideas with those who have an interest in the pituitary gland and its disorders. We are affected patients, their